Top Pharma Companies in India by Market Cap

BSE Sensex 74608.57 250.42 (-0.33%)

Filter

Top Pharma Companies in India as on Sep-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Abbott India Ltd.	Q V PT	57,954 Mid Cap	27,196 (0.86%)	35.48	11.07	9.96	17.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Neuland Laboratories Ltd.	Q V+ PT	29,349 Small Cap	22,818.65 (0.96%)	58.25	14.35	16.64	37.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Divis Laboratories Ltd.	Q V+ PT	2,48,664 Large Cap	9,366 (-0.70%)	85.6	14.18	8.67	4.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,26,103 Large Cap	8,917.50 (-0.25%)	81.82	12.46	14.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Astrazeneca Pharma India Ltd.	Q V PT	16,879 Small Cap	6,706.45 (0.64%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Kovai Medical Center & Hospital Ltd.	Q V PT	6,820 Small Cap	6,148.45 (-0.40%)	26.35	4.87	18.09	25.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Procter & Gamble Health Ltd.	Q V PT	9,133 Small Cap	5,446.45 (-1.08%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Alkem Laboratories Ltd.	Q V PT	65,780 Mid Cap	5,379 (0.54%)	29.65	4.47	10.66	8.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Dr Agarwals Eye Hospital Ltd.	Q V PT	2,598 Small Cap	5,244 (-0.41%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Torrent Pharmaceuticals Ltd.	Q V+ PT	1,82,738 Large Cap	4,954 (-0.28%)	86.64	21.05	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Pfizer Ltd.	Q V PT	18,305 Small Cap	4,015 (-0.59%)	25.13	4.19	2.39	8.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Sanofi Consumer Healthcare India Ltd.	Q V+ PT	9,249 Small Cap	3,995 (-0.22%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Kwality Pharmaceuticals Ltd.	Q V+ PT	3,606 Small Cap	3,702.80 (-3.50%)	49.12	11.17	13.94	34.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Ajanta Pharma Ltd.	Q V+ PT	44,562 Mid Cap	3,532.40 (-0.07%)	38.92	9.09	13.54	10.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Acutaas Chemicals Ltd.	Q V+ PT	28,149 Small Cap	3,297.05 (-3.66%)	72.55	16.24	31.50	70.35	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Sanofi India Ltd.	Q V PT	7,112 Small Cap	3,058 (-0.63%)	17.15	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Gland Pharma Ltd.	Q V PT	48,875 Mid Cap	2,912.15 (-1.00%)	43	4.57	13.18	0.09	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Glaxosmithkline Pharmaceuticals Ltd.	Q V+ PT	48,312 Mid Cap	2,870.45 (0.23%)	45.42	19.25	5.49	17.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Caplin Point Laboratories Ltd.	Q V PT	20,887 Small Cap	2,806.45 (1.80%)	31.5	5.71	15.56	20.24	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	RPG Life Sciences Ltd.	Q V+ PT	4,640 Small Cap	2,785.10 (0.65%)	39.74	7.19	42.67	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	NGL Fine-Chem Ltd.	Q V PT	1,716 Small Cap	2,717.90 (-0.46%)	29.49	4.85	14.19	-3.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Mankind Pharma Ltd.	Q V PT	95,744 Mid Cap	2,461.25 (1.29%)	49.13	5.96	18.10	8.40	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Glenmark Pharmaceuticals Ltd.	Q V+ PT	67,169 Mid Cap	2,450.50 (0.02%)	38.46	6.31	9.19	22.19	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Wockhardt Ltd.	Q V+ PT	33,911 Small Cap	2,194.45 (0.31%)	86.91	7.06	4.49	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Hester Biosciences Ltd.	Q V PT	1,861 Small Cap	2,190.75 (0.20%)	13.66	4.09	9.19	6.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	CORONA Remedies Ltd.	Q V+ PT	13,448 Small Cap	2,185.70 (-1.29%)	68.04	16.78	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Lupin Ltd.	Q V PT	98,070 Mid Cap	2,123.50 (0.17%)	17.53	4.07	13.02	32.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Laurus Labs Ltd.	Q V+ PT	1,05,645 Mid Cap	2,014.65 (-0.17%)	99.72	19.34	7.19	-2.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Novartis India Ltd.	Q V+ PT	5,080 Small Cap	2,005 (0.11%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Ipca Laboratories Ltd.	Q V+ PT	51,020 Mid Cap	2,001.70 (-0.32%)	40.96	6.1	7.35	1.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anlon Healthcare	29.04	10%
Ind-Swift Labs.	408.25	7%
Shukra Pharmaceut.	58.90	6.63%
Aarti Pharmalabs	892.45	5.43%
Kilitch Drugs(India)	213.20	5%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Take	15.80	-4.13%
Guj. Kidney & Super	176	-3.90%
Acutaas Chemicals	3,297.05	-3.66%
Kopran	272.75	-3.64%
Kwality Pharma	3,702.80	-3.50%

News about Top Pharma Companies in India

Sep, 2026

Glenmark Pharmaceuticals informs about analyst meet

Pursuant to the Regulation 30 and Para A of Part A of Schedule III of the SEBI LODR, Glenmark Pharmaceuticals has informed that the company will be meeting Investor/Analyst (Participants) in PL Capital - Emerging Titans 2026 Conference on 29-09-2026. No unpublished price sensitive information is proposed to be shared during the meeting.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Kovai Medical Center and Hospital informs about closure of trading window

Pursuant to Clause 4 of Schedule B of SEBI (Prohibition of Insider Trading) Regulations 2015, as amended and the Company's Code of Conduct for Prevention of Insider Trading, Kovai Medical Center and Hospital has informed that the Trading Window for trading in Company's Securities shall remain closed from 1st October 2026 till the end of 48 hours after the declaration of Un-audited Financial Results for the Quarter / Half year ended 30th September 2026 for insiders, designated persons and their immediate relatives. The date of Board Meeting for declaration of Un-audited Financial Results or the Company for the Quarter / Half year ended 30th September, 2026 will be intimated in due course.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Corona Remedies informs about analyst meet

Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Corona Remedies has informed that the officials of the Company will be meeting analysts / investors on Wednesday, September 23, 2026 at 2:00 pm organized by JP Morgan in Ahmedabad. Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This intimation is also being made available on the website of the Company at www.coronaremedies.com.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Alkem Laboratories inches up on launching NeuCeno for treatment of partial-onset seizures in adult patients

Epilepsy is a significant healthcare burden in India, with an estimated 9.4 million people living with the condition

Sep, 2026

Alkem Laboratories launches NeuCeno for treatment of partial-onset seizures in adult patients

Epilepsy is a significant healthcare burden in India, with an estimated 9.4 million people living with the condition

Sep, 2026

Alkem Laboratories informs about press release

Alkem Laboratories has informed that the Company today announced the launch of NeuCeno (cenobamate), anti-seizure medication (ASM) for the treatment of partialonset seizures in adult patients. A press release in this regard is enclosed.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Abbott India Ltd.	57,954 Crore
2	Neuland Laboratories Ltd.	29,349 Crore
3	Divis Laboratories Ltd.	2,48,664 Crore
4	Apollo Hospitals Enterprise Ltd.	1,26,103 Crore
5	Astrazeneca Pharma India Ltd.	16,879 Crore
6	Kovai Medical Center & Hospital Ltd.	6,820 Crore
7	Procter & Gamble Health Ltd.	9,133 Crore
8	Alkem Laboratories Ltd.	65,780 Crore
9	Dr Agarwals Eye Hospital Ltd.	2,598 Crore
10	Torrent Pharmaceuticals Ltd.	1,82,738 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,196	57,954	35.89	11.20	24.65	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,954	1,82,738	83.79	20.36	38.34	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,451	67,169	37.36	6.13	12.46	27.89
Lupin Ltd. (M)	Somewhat Good	2,124	98,070	17.74	4.12	9.82	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,532	44,562	39.27	9.17	26.53	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,015	1,05,645	117
Sai Life Sciences Ltd. (S)	Somewhat Good	1,606	34,003	76.91
Aurobindo Pharma Ltd. (M)	Very Good	1,694	99,828	53.55
Divis Laboratories Ltd. (L)	Very Good	9,366	2,48,664	52.16
Gland Pharma Ltd. (M)	Very Good	2,912	48,875	45.50
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,606	34,003	94.00	13.32	48.48	23.61
Mankind Pharma Ltd. (M)	Very Good	2,461	95,744	46.87	5.69	24.40	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,532	44,562	39.27	9.17	26.53	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,168	1,15,012	25.48	4.27	14.28	13.52
Gland Pharma Ltd. (M)	Very Good	2,912	48,875	43.30	4.60	22.09	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,606	34,003	94.00	13.32	48.48	39.96
Lupin Ltd. (M)	Somewhat Good	2,124	98,070	17.74	4.12	9.82	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,451	67,169	37.36	6.13	12.46	22.19
Abbott India Ltd. (M)	Very Good	27,196	57,954	35.89	11.20	24.65	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,212	97,749	30.34	2.56	15.56	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Glenmark Pharmaceuticals informs about analyst meet

Kovai Medical Center and Hospital informs about closure of trading window

Corona Remedies informs about analyst meet

Alkem Laboratories inches up on launching NeuCeno for treatment of partial-onset seizures in adult patients

Alkem Laboratories launches NeuCeno for treatment of partial-onset seizures in adult patients

Alkem Laboratories informs about press release

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?